Client Result

Infectious Pathogen Diagnostics Technology Commercialization

Project Overview

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

DeciBio Approach

Primary Research

  • Conducted 50 in-depth stakeholder interviews with laboratory directors and hospital policy implementation supervisors in multiple settings across 7 different countries
  • Interviews centered around technology usage, procurement responsibilities, interactions with other stakeholders, purchasing drivers / barriers, product evaluation criteria, pain points and unmet needs, and feedback on the client’s product profile

Quantitative Analysis

  • Built a bottoms-up model of the pathogen screening / surveillance market segmented by technology, geography, setting, pathogen, etc., with 3 distinct model scenarios
At a glance
Stakeholder Interviews
Model Segmentations
Countries Researched and Modelled

Based on research and analysis, DeciBio identified key purchasing stakeholders, outlined testing and purchasing workflows, and recommended commercialization and market development tactics


8 weeks

Geographic Scope

U.S., EU


Clinical Diagnostics


Voice-Of-Customer Research

Addressable Market Sizing

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.